ResoTher Pharma A/S
- Address
- Dronninggaards Alle 136
Sponsor Overview
Specializations
Cardiovascular Medicine
ResoTher Pharma A/S focuses on clinical research in ST-Elevation Myocardial Infarction (STEMI), addressing acute cardiac injury and the urgent treatment needs associated with myocardial infarction.
- Acute coronary syndromes
- Myocardial infarction
- ST-Elevation Myocardial Infarction
The sponsor’s therapeutic interest is centered on improving outcomes in severe ischemic heart disease and related cardiovascular conditions.
Acute Cardiac Care
The company’s trial activity is directed toward patients requiring rapid intervention after a major cardiac event, with attention to safety and tolerability in an acute care setting.
- Emergency cardiology
- Reperfusion-related care
- Post-infarction management
This area reflects interest in therapies intended for use during the early management of STEMI and its immediate clinical consequences.
Therapeutic Development in Cardiology
ResoTher Pharma A/S is engaged in the evaluation of a pharmaceutical candidate within cardiovascular therapeutics, with emphasis on both efficacy and patient safety.
- Investigational cardiovascular agents
- Placebo-controlled cardiac studies
- Clinical assessment of tolerability
The sponsor’s research activity lies in the development of treatments for serious ischemic heart conditions.
Multicentre Clinical Evaluation
The sponsor’s research landscape includes multicentre clinical work across multiple sites and countries, supporting the assessment of therapies in a broader cardiology population.
- Cross-site clinical collaboration
- International cardiovascular research
- Recruiting patient populations
This structure supports the study of treatment options for patients with acute coronary disease in routine clinical settings.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of RTP-026 Sodium in a Randomized, Double-Blind, Placebo-Controlled Trial for Safety and Efficacy in ST-Elevation Myocardial Infarction Patients |  Denmark Sweden | Not Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.
This sponsor has worked with 4 sites across their trial portfolio.
Therapeutic Focus
- 1.Cardiovascular Diseases1 trial359 other sponsors
Partnered Research Centres
4 centres- Address
- Palle Juul-Jensens Boulevard 99, 8200 Aarhus
- Address
- Getingevaegen 4, 222 42 Lund
- Address
- Kloevervaenget 47, 5000 Odense
- Address
- Blegdamsvej 9, 2100 Copenhagen
Want to get in touch with this sponsor?
Send a question and we'll pass it on to ResoTher Pharma A/S.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.